370 related articles for article (PubMed ID: 32010931)
1. Methylenetetrahydrofolate reductase C677T (Ala>Val, rs1801133 C>T) polymorphism decreases the susceptibility of hepatocellular carcinoma: a meta-analysis involving 12,628 subjects.
Zhang S; Jiang J; Tang W; Liu L
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32010931
[TBL] [Abstract][Full Text] [Related]
2. Association between methylenetetrahydrofolate reductase tagging polymorphisms and susceptibility of hepatocellular carcinoma: a case-control study.
Zhang S; Lin J; Jiang J; Chen Y; Tang W; Liu L
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31694048
[TBL] [Abstract][Full Text] [Related]
3. Significant association between MTHFR C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Sun H; Han B; Zhai H; Cheng X; Ma K
Tumour Biol; 2014 Jan; 35(1):189-93. PubMed ID: 24132589
[TBL] [Abstract][Full Text] [Related]
4. Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk: An update meta-analysis and trial sequential analysis.
Wang B; Ma M; Guo X; Yan Y; Li L
Medicine (Baltimore); 2021 Oct; 100(41):e27527. PubMed ID: 34731145
[TBL] [Abstract][Full Text] [Related]
5. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
Jiao X; Luo Y; Yang B; Jing L; Li Y; Liu C; Jing X; Wang F; Wang Y; Du Z; Gao Y
Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187
[TBL] [Abstract][Full Text] [Related]
6. Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk in Chinese population.
Qi X; Sun X; Xu J; Wang Z; Zhang J; Peng Z
Tumour Biol; 2014 Mar; 35(3):1757-62. PubMed ID: 24385382
[TBL] [Abstract][Full Text] [Related]
7. The association between MTHFR gene polymorphisms and hepatocellular carcinoma risk: a meta-analysis.
Qin X; Peng Q; Chen Z; Deng Y; Huang S; Xu J; Li H; Li S; Zhao J
PLoS One; 2013; 8(2):e56070. PubMed ID: 23457501
[TBL] [Abstract][Full Text] [Related]
8. Association between the methylenetetrahydrofolate reductase C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Jin F; Qu LS; Shen XZ
Diagn Pathol; 2009 Nov; 4():39. PubMed ID: 19930673
[TBL] [Abstract][Full Text] [Related]
9. The MTHFR polymorphism affect the susceptibility of HCC and the prognosis of HCC liver transplantation.
Wang C; Xie H; Lu D; Ling Q; Jin P; Li H; Zhuang R; Xu X; Zheng S
Clin Transl Oncol; 2018 Apr; 20(4):448-456. PubMed ID: 29185200
[TBL] [Abstract][Full Text] [Related]
10. Genetic Polymorphism of MTHFR C677T Influences Susceptibility to HBV-Related Hepatocellular Carcinoma in a Chinese Population: a Case-Control Study.
Qiao K; Zhang S; Trieu C; Dai Q; Huo Z; Du Y; Lu W; Hou W
Clin Lab; 2017 Apr; 63(4):787-795. PubMed ID: 28397480
[TBL] [Abstract][Full Text] [Related]
11. Correlation Between
Su H
Nutr Cancer; 2019; 71(7):1055-1060. PubMed ID: 31282757
[TBL] [Abstract][Full Text] [Related]
12. Correlation between Methylenetetrahydrofolate Reductase Polymorphisms and Hepatocellular Carcinoma: A Meta-Analysis.
Su H; Zhang G
Ann Nutr Metab; 2019; 74(3):251-256. PubMed ID: 30917367
[TBL] [Abstract][Full Text] [Related]
13. Significant association between the MTHFR A1298C polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Chang W; Meng Q; Liu JH; Wu LX; Chen Y; Chen SD
Genet Mol Res; 2015 Dec; 14(4):15972-80. PubMed ID: 26662389
[TBL] [Abstract][Full Text] [Related]
14. Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population.
Mu LN; Cao W; Zhang ZF; Cai L; Jiang QW; You NC; Goldstein BY; Wei GR; Chen CW; Lu QY; Zhou XF; Ding BG; Chang J; Yu SZ
Cancer Causes Control; 2007 Aug; 18(6):665-75. PubMed ID: 17503006
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of MTHFR C677T and A1298C gene polymorphisms: association with the risk of hepatocellular carcinoma.
Qi YH; Yao LP; Cui GB; Liang J; Shao QJ; Yan LF; Du P
Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):172-80. PubMed ID: 24316043
[TBL] [Abstract][Full Text] [Related]
16. Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population.
Kwak SY; Kim UK; Cho HJ; Lee HK; Kim HJ; Kim NK; Hwang SG
Anticancer Res; 2008; 28(5A):2807-11. PubMed ID: 19035314
[TBL] [Abstract][Full Text] [Related]
17. [A study on the association of MTHFR C677T polymorphism with genetic susceptibility to hepatocellular carcinoma].
Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ
Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):196-8. PubMed ID: 16556414
[TBL] [Abstract][Full Text] [Related]
18. Interrelationships among genetic C677T polymorphism of 5,10-methylenetetrahydrofolate reductase, biochemical folate status, and lymphocytic p53 oxidative damage in association with tumor malignancy and survivals of patients with hepatocellular carcinoma.
Kuo CS; Huang CY; Kuo HT; Cheng CP; Chen CH; Lu CL; Yang FL; Syu Huang RF
Mol Nutr Food Res; 2014 Feb; 58(2):329-42. PubMed ID: 23996892
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis supports association of a functional SNP (rs1801133) in the MTHFR gene with Parkinson's disease.
Zhu ZG; Ai QL; Wang WM; Xiao ZC
Gene; 2013 Nov; 531(1):78-83. PubMed ID: 23916622
[TBL] [Abstract][Full Text] [Related]
20. Association between
Tan X; Chen H
Front Endocrinol (Lausanne); 2023; 14():1273218. PubMed ID: 37964957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
